FDA – Medtronic Announces Recall of its Stratamr Adjustable Valves and Shunts

Medtronic Announces Voluntary Worldwide Recall of its Stratamr Adjustable Valves and Shunts

READ MORE: https://www.fda.gov/Safety/Recalls/ucm551646.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery 

DUBLIN – April 6, 2017 – Medtronic plc (NYSE: MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR™ adjustable valves and shunts. These products are manufactured and marketed by Medtronic’s Neurosurgery business, which is part of the Brain Therapies division of the company’s Restorative Therapies Group. This recall only applies to StrataMR adjustable valves and shunts and does not apply to Strata™ II or Strata™ NSC products.

As of the initiation of this recall, 2,622 StrataMR valves and shunts potentially affected by this recall had been distributed worldwide. The affected StrataMR valves and shunts were manufactured from October 27, 2015 to November 11, 2016. Medtronic initiated the recall due to an increase in the product complaint rate. As of April 1, 2017, the product complaint rate related to this issue was 2.75 percent of total units distributed.

…. Continue ….

READ MORE: https://www.fda.gov/Safety/Recalls/ucm551646.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery 

neurocirurgiabr

Neurosurgery from Brazil.To provide neurosurgeouns with the most timely comprehensive and relevant clinical information to improve patient care; we offer a web site where patients can view our patient-level information for free

You may also like...

Leave a Reply

%d bloggers like this: